Video

How Does the Pharmacy Ownership Program Help Independent Pharmacy Owners?

Conference|AmerisourceBergen & Good Neighbor Pharmacy ThoughtSpot

Jennifer Zilka, Vice President of Business Coaching and Pharmacy Ownership for Good Neighbor Pharmacy, talks about how the pharmacy ownership program helps independent pharmacy owners maximize their business.

Jennifer Zilka, Vice President of Business Coaching and Pharmacy Ownership for Good Neighbor Pharmacy, talks about how the pharmacy ownership program helps independent pharmacy owners maximize their business.

Related Videos
Woman experiencing pain related to recurrent pericarditis -- Image credit: Art_Photo | stock.adobe.com
Pharmacist assisting a patient with pericarditis -- Image credit: Yuri Arcurs/peopleimages.com | stock.adobe.com
Related Content
Lower back pain, cLLD -- Image credit: JaRiRiyawat | stock.adobe.com
February 23rd 2025

FDA Grants Fast Track Designation to BRTX-100 to Treat Chronic Lumbar Disc Disease

Gillian McGovern, Associate Editor
Pharmacy Focus: GLP-1 Medications and Pharmacists' Role in Counseling Patients
January 31st 2025

Pharmacy Focus: GLP-1 Medications and Pharmacists' Role in Counseling Patients

Luke Halpern, Assistant Editor
Amlodipine tablets | Image Credit: © Ming - stock.adobe.com
February 21st 2025

A Common Blood Pressure Medication May Help Treat Symptoms of ADHD

Alexandra Gerlach, Associate Editor
Public Health Matters: The Importance of Reproductive Justice and Black Maternal Health
December 24th 2024

Public Health Matters: The Importance of Reproductive Justice and Black Maternal Health

Christina M. Madison, PharmD, FCCP, AAHIVP
A crosssection of a foot showing the progression of diabetic foot ulcers - Image credit: Moviebirth | stock.adobe.com
February 21st 2025

FDA Grants Breakthrough Therapy Designation to SkinTE for Diabetic Foot Ulcers

Kennedy Ferruggia, Assistant Editor
FDA approval stamp for chenodiol -- Image credit: Olivier Le Moal | stock.adobe.com
Published: February 21st 2025 | Updated: February 21st 2025

Chenodiol, First Treatment for Cerebrotendinous Xanthomatosis, Receives FDA Approval

Gillian McGovern, Associate Editor